|
CA1320906C
(en)
|
1986-06-04 |
1993-08-03 |
Daniel R. Twardzik |
Interleukin-2 induced antineoplastic peptide
|
|
JPH04503607A
(ja)
|
1989-02-24 |
1992-07-02 |
イムノセラピューティックス・インコーポレイテッド |
固定化サイトカイン類
|
|
GR1001034B
(el)
|
1989-07-21 |
1993-03-31 |
Ortho Pharma Corp |
Μεθοδος διεγερσης του πολλαπλασιασμου λεμφοκυτταρων περιφερειακου αιματος.
|
|
US5415874A
(en)
|
1989-10-31 |
1995-05-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Natural killer cell lines and clones with antigen specificity
|
|
US6194204B1
(en)
|
1996-08-02 |
2001-02-27 |
Center For Blood Research, Inc. |
Enrichment of dendritic cells from blood
|
|
DE19813759C1
(de)
|
1998-03-27 |
1999-07-15 |
Gsf Forschungszentrum Umwelt |
Verfahren zur Induktion einer durch NK-Zellen vermittelten Immunantwort
|
|
US6307024B1
(en)
|
1999-03-09 |
2001-10-23 |
Zymogenetics, Inc. |
Cytokine zalpha11 Ligand
|
|
JP2004527263A
(ja)
|
2001-05-30 |
2004-09-09 |
フォンダツィオーネ テレソン |
免疫抑制活性を有するエクスビボ単離ｃｄ２５＋ｃｄ４＋ｔ細胞とその使用
|
|
US20030068306A1
(en)
|
2001-09-14 |
2003-04-10 |
Dilber Mehmet Sirac |
Medium
|
|
US7544355B2
(en)
|
2002-03-13 |
2009-06-09 |
Universita Degli Studi Di Perugia |
Methods and compositions for allogeneic transplantation
|
|
EP2377547A1
(en)
|
2002-06-07 |
2011-10-19 |
ZymoGenetics, Inc. |
Use of IL-21 as an antimicrobial agent
|
|
WO2004009021A2
(en)
|
2002-07-18 |
2004-01-29 |
University Of Washington |
Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
|
|
US20050191743A1
(en)
|
2002-10-03 |
2005-09-01 |
Wu J.H. D. |
Three-dimensional peripheral lymphoid organ cell cultures
|
|
JP4033390B2
(ja)
|
2002-10-30 |
2008-01-16 |
独立行政法人科学技術振興機構 |
不死化ナチュラルキラー細胞株
|
|
WO2006004592A2
(en)
|
2004-05-28 |
2006-01-12 |
Mayo Foundation For Medical Education And Research |
Methods for autologous stem cell transplantation
|
|
US20090104170A1
(en)
|
2004-11-02 |
2009-04-23 |
Richard William Wyatt Childs |
Compositions and methods for treating hyperproliferative disorders
|
|
AU2005309502B2
(en)
|
2004-11-24 |
2011-11-17 |
Hill's Pet Nutrition, Inc. |
Methods for increasing the immune response in an animal
|
|
EP1863905B1
(en)
|
2005-03-17 |
2016-01-20 |
UCL Business PLC |
Method for activating natural killer cells by tumour cell preparations in vitro
|
|
EP1739166B1
(en)
|
2005-07-01 |
2011-06-22 |
TxCell S.A. |
Obtention of food- or auto-antigen specific Tr1 cells from a leukocyte or PBMC population
|
|
US9121008B2
(en)
|
2005-08-31 |
2015-09-01 |
University Of Utah Research Foundation |
Development of natural killer cells and functional natural killer cell lines
|
|
EP1941027B1
(en)
|
2005-09-28 |
2014-08-20 |
IPD-Therapeutics B.V. |
Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics.
|
|
CA2645042A1
(en)
|
2006-03-06 |
2007-09-13 |
Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services |
Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer
|
|
WO2008118369A2
(en)
|
2007-03-22 |
2008-10-02 |
Dendreon Corporation |
Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity
|
|
CA2682243C
(en)
|
2007-03-27 |
2019-07-23 |
Ipd-Therapeutics B.V. |
Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics
|
|
KR100902340B1
(ko)
|
2007-08-02 |
2009-06-12 |
한국생명공학연구원 |
Ｙｃ－１ 또는 ｉｌ－２１을 유효성분으로 포함하는자연살해세포 분화제 및 분화 방법
|
|
DK2520643T3
(da)
|
2007-12-07 |
2020-01-20 |
Miltenyi Biotec Bv & Co Kg |
Prøvebehandlingssystemer og -fremgangsmåder
|
|
KR101133185B1
(ko)
|
2008-07-29 |
2012-04-06 |
서울대학교병원 |
자연살해세포의 증식방법
|
|
KR101077912B1
(ko)
*
|
2008-10-24 |
2011-10-31 |
주식회사 메디셀 |
제대혈로부터 효율적인 자연살해세포의 증식 및 분화 방법
|
|
KR101720961B1
(ko)
|
2009-02-27 |
2017-03-29 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
다능성 세포의 분화
|
|
ES2763169T3
(es)
|
2009-03-26 |
2020-05-27 |
Cellprotect Nordic Pharmaceuticals Ab |
Expansión de células NK
|
|
TW201127959A
(en)
|
2010-02-12 |
2011-08-16 |
Ivy Life Sciences Co Ltd |
Method of producing immune killer cell
|
|
US20130059379A1
(en)
|
2010-02-24 |
2013-03-07 |
Ingo Schmidt-Wolf |
Method for the generation of a cik cell and nk cell population
|
|
JP5996533B2
(ja)
|
2010-07-13 |
2016-09-21 |
アントフロゲネシス コーポレーション |
ナチュラルキラー細胞を生成させる方法
|
|
KR101145391B1
(ko)
|
2010-08-16 |
2012-05-15 |
고려대학교 산학협력단 |
말초혈액으로부터 자연 살해세포의 증식 방법
|
|
TWI439275B
(zh)
|
2010-12-31 |
2014-06-01 |
Glory Biomedical Co Ltd |
一種人類自然殺手細胞之體外增殖方法
|
|
KR20120093002A
(ko)
|
2011-02-14 |
2012-08-22 |
(주)에이티젠 |
Ｎｋ 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트
|
|
CA2830080C
(en)
|
2011-03-18 |
2021-10-26 |
Jan Spanholtz |
Generation of nk cells and nk-cell progenitors
|
|
JP5572863B2
(ja)
|
2011-06-24 |
2014-08-20 |
国立大学法人九州大学 |
Ｎｋ細胞の増幅方法
|
|
JP6010136B2
(ja)
|
2011-12-22 |
2016-10-19 |
モガム バイオテクノロジー インスティチュート |
ナチュラルキラー細胞の製造方法、その方法により製造されたナチュラルキラー細胞、並びにそれを含む腫瘍及び感染性疾患治療用組成物
|
|
US20150010583A1
(en)
|
2012-02-08 |
2015-01-08 |
Ipd-Therapeutics B.V. |
Ex vivo nk cell differentiation from cd34+ hematopoietic cells
|
|
JP6339998B2
(ja)
|
2012-04-24 |
2018-06-06 |
ダン エス． カウフマン， |
幹細胞よりナチュラルキラー細胞を発生させる方法
|
|
KR101520534B1
(ko)
|
2012-05-07 |
2015-05-21 |
고려대학교 산학협력단 |
말초혈액단핵구 유래 자연 살해세포의 유도 및 증식 방법
|
|
DK3578201T3
(da)
|
2012-06-28 |
2023-05-08 |
Univ Of Central Florida Research Foundation Incorporated |
Fremgangsmåder og sammensætninger til naturlige dræberceller
|
|
US9175266B2
(en)
*
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
|
JP5856025B2
(ja)
|
2012-08-02 |
2016-02-09 |
阿部 博幸 |
単球またはｎｋ細胞を入手する方法
|
|
CN102988415B
(zh)
|
2012-08-15 |
2014-11-19 |
中航（宁夏）生物有限责任公司 |
人异基因有核细胞工业化制备自然杀伤性细胞(nk)及注射液
|
|
WO2014079946A1
(en)
|
2012-11-21 |
2014-05-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for determining the risk of acute graft versus host disease
|
|
CN104919042A
(zh)
|
2013-01-15 |
2015-09-16 |
阿部博幸 |
含免疫细胞组合物的制造方法及癌治疗用组合物
|
|
CN115137753A
(zh)
*
|
2013-02-05 |
2022-10-04 |
细胞结构公司 |
来自胎盘的自然杀伤细胞
|
|
US9546203B2
(en)
|
2013-03-14 |
2017-01-17 |
Amgen Inc. |
Aglycosylated Fc-containing polypeptides with cysteine substitutions
|
|
EP4032540A1
(en)
|
2013-04-19 |
2022-07-27 |
Cytune Pharma |
Cytokine derived treatment with reduced vascular leak syndrome
|
|
SG11201602979RA
(en)
|
2013-10-17 |
2016-05-30 |
Univ Singapore |
Chimeric receptor that triggers antibody-dependent cell cytotoxicity against multiple tumors
|
|
CA2935459C
(en)
|
2014-01-03 |
2021-04-27 |
FullHope Biomedical Co., Ltd. |
Modified natural killer cells, compositions and uses thereof
|
|
WO2015125113A1
(en)
|
2014-02-21 |
2015-08-27 |
Dr. Reddy's Laboratories Limited |
Method of culturing high cell density pbmc's
|
|
ES2880718T3
(es)
*
|
2014-03-07 |
2021-11-25 |
Emercell Sas |
Células NK de sangre del cordón umbilical combinadas y sus usos para el tratamiento del cáncer y enfermedades infecciosas crónicas
|
|
WO2015154012A1
(en)
|
2014-04-03 |
2015-10-08 |
Memorial Sloan-Kettering Cancer Center |
Clonogenic natural killer (nk) cell populations and methods of producing and using such populations
|
|
AU2015259877B2
(en)
|
2014-05-15 |
2021-02-25 |
National University Of Singapore |
Modified natural killer cells and uses thereof
|
|
EP3838288A1
(en)
|
2014-06-11 |
2021-06-23 |
polybiocept GmbH |
Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy
|
|
JP2016008198A
(ja)
|
2014-06-24 |
2016-01-18 |
国立大学法人名古屋大学 |
間質性膀胱炎の治療
|
|
CN106687581A
(zh)
|
2014-07-07 |
2017-05-17 |
塔尔加泽梅股份有限公司 |
用于治疗用途的岩藻糖基化细胞的制备和冷冻干燥
|
|
JP2016077185A
(ja)
|
2014-10-14 |
2016-05-16 |
学校法人 聖マリアンナ医科大学 |
γδＴ細胞の製造方法および医薬
|
|
SMT202100055T1
(it)
|
2014-11-19 |
2021-03-15 |
Axon Neuroscience Se |
Anticorpi tau umanizzati nella malattia di alzheimer
|
|
EP3034092A1
(en)
|
2014-12-17 |
2016-06-22 |
Université de Lausanne |
Adoptive immunotherapy for treating cancer
|
|
CA2972806A1
(en)
|
2014-12-31 |
2016-07-07 |
Anthrogenesis Corporation |
Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
|
|
WO2016122014A1
(ko)
|
2015-01-27 |
2016-08-04 |
한국생명공학연구원 |
자연살해세포의 대량생산 방법 및 상기 방법으로 수득된 자연살해세포의 항암제로서의 용도
|
|
CN104705291A
(zh)
|
2015-04-03 |
2015-06-17 |
广州赛莱拉干细胞科技股份有限公司 |
一种脐血单个核细胞冻存液、应用、制备方法
|
|
GB201509202D0
(en)
|
2015-05-28 |
2015-07-15 |
Ge Healthcare Bio Sciences Ab |
Semi-static cell culture
|
|
WO2016209021A1
(ko)
|
2015-06-24 |
2016-12-29 |
주식회사 차바이오텍 |
자연살해세포의 증식 방법 및 자연살해세포 증식용 조성물
|
|
KR101851270B1
(ko)
|
2015-07-10 |
2018-04-25 |
고려대학교 산학협력단 |
자연 살해세포의 대량증식 방법 및 배양용 조성물
|
|
EP3138905A1
(en)
*
|
2015-09-04 |
2017-03-08 |
Miltenyi Biotec GmbH |
Method for natural killer cell expansion
|
|
JP2019503349A
(ja)
|
2015-12-17 |
2019-02-07 |
ノバルティス アーゲー |
Ｐｄ−１に対する抗体分子およびその使用
|
|
CN105524880A
(zh)
|
2016-01-27 |
2016-04-27 |
上海润泉生物技术有限公司 |
一种免疫细胞库的构建方法
|
|
CN107267454B
(zh)
|
2016-04-07 |
2025-05-23 |
内蒙古原生元生物科技有限公司 |
一种脐血nk细胞的体外扩增方法及其试剂盒与应用
|
|
KR101968184B1
(ko)
*
|
2016-04-29 |
2019-04-15 |
고려대학교 산학협력단 |
저산소 조건을 이용한 면역세포의 증식 배양 방법
|
|
WO2017196657A1
(en)
*
|
2016-05-07 |
2017-11-16 |
Anthrogenesis Corporation |
Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells
|
|
EP3487991B1
(en)
|
2016-07-25 |
2022-09-07 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Methods of producing modified natural killer cells and methods of use
|
|
CA3039532A1
(en)
|
2016-10-05 |
2018-04-12 |
University Of Central Florida Research Foundation, Inc. |
Methods and compositions related to nk cell and anti-pdl1 cancer therapies
|
|
US10300089B2
(en)
|
2016-11-08 |
2019-05-28 |
University Of Central Florida Research Foundation, Inc. |
Methods for high scale therapeutic production of memory NK cells
|
|
KR102623244B1
(ko)
|
2016-12-21 |
2024-01-09 |
주식회사 엔케이맥스 |
면역 세포 및 포나티닙을 포함하는 약학 조성물 및 방법
|
|
WO2018161026A1
(en)
*
|
2017-03-03 |
2018-09-07 |
Obsidian Therapeutics, Inc. |
Il15 compositions and methods for immunotherapy
|
|
KR101948534B1
(ko)
|
2017-04-20 |
2019-02-15 |
주식회사 이뮤니스바이오 |
세포밀도 조절을 이용한 자연살해세포의 대량증식방법
|
|
AU2018271755B2
(en)
|
2017-05-26 |
2021-12-23 |
Green Cross Lab Cell Corporation |
Method for culturing natural killer cell, using transformed T cell
|
|
WO2019014684A1
(en)
|
2017-07-14 |
2019-01-17 |
Ohio State Innovation Foundation |
EXPANSION OF IMMUNE CELLS WITH INTERLEUKIN-INDUCIBLE T CELL KINASE-INHIBITING COMPOUNDS
|
|
SG11202000939PA
(en)
|
2017-08-03 |
2020-02-27 |
Synthorx Inc |
Cytokine conjugates for the treatment of proliferative and infectious diseases
|
|
US20210128567A1
(en)
|
2017-08-29 |
2021-05-06 |
Flaask, Llc |
Compositions and Methods for Cognitive, Immune and Digestive Support in Patients with Autism Spectrum Disorder
|
|
CN107970258B
(zh)
|
2017-11-20 |
2020-11-10 |
英普乐孚生物技术(上海)有限公司 |
一种嵌合抗原受体t细胞制剂
|
|
EP3746095A4
(en)
|
2018-02-01 |
2021-04-21 |
Nkmax Co., Ltd. |
Method of producing natural killer cells and composition for treating cancer
|
|
KR102765799B1
(ko)
|
2018-02-01 |
2025-02-13 |
주식회사 엔케이맥스 |
Cd56+ 자연살해세포를 포함하는 항암용 조성물
|
|
KR102732845B1
(ko)
|
2018-02-01 |
2024-11-25 |
주식회사 엔케이맥스 |
자연살해세포의 생산방법
|
|
WO2019152663A1
(en)
|
2018-02-01 |
2019-08-08 |
Nkmax Co., Ltd. |
Method of producing natural killer cells and composition for treating cancer
|
|
BR112020016876A2
(pt)
|
2018-02-21 |
2020-12-15 |
Board Of Regents, The University Of Texas System |
Células apresentadoras de antígeno universal e usos das mesmas
|
|
WO2019168222A1
(ko)
|
2018-02-28 |
2019-09-06 |
주식회사 제넨셀 |
말초혈액단핵구 유래 항암 활성화 림프구 배양용 배지 조성물 및 이를 이용한 항암 활성화 림프구 배양방법
|
|
ES2973728T3
(es)
|
2018-03-13 |
2024-06-24 |
Fundacion Para La Investigacion Biomedica Del Hospital Univ La Paz |
Anticuerpo anti-CXCR4 combinado con linfocitos citolíticos naturales activados y expandidos para inmunoterapia contra el cáncer
|
|
EP3539552A1
(en)
|
2018-03-16 |
2019-09-18 |
Deutsches Rheuma-Forschungszentrum Berlin |
Activation and expansion of nkg2c+ nk cells
|
|
WO2019182392A1
(ko)
|
2018-03-23 |
2019-09-26 |
주식회사 녹십자랩셀 |
자연살해세포의 제조방법
|
|
SG11202010763VA
(en)
|
2018-05-03 |
2020-11-27 |
Univ Texas |
Natural killer cells engineered to express chimeric antigen receptors with immune checkpoint blockade
|
|
WO2019229109A1
(en)
|
2018-05-30 |
2019-12-05 |
Glycostem Therapeutics B.V. |
Car nk cells
|
|
WO2020006139A1
(en)
|
2018-06-27 |
2020-01-02 |
The George Washington University |
Targeting stat sumoylation to enhance immune responses
|
|
US11419898B2
(en)
|
2018-10-17 |
2022-08-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
CN109294985B
(zh)
|
2018-10-25 |
2022-02-18 |
江苏普瑞康生物医药科技有限公司 |
一种用于nk细胞体外扩增的培养基体系及nk细胞体外扩增的方法
|
|
BR112021008461A2
(pt)
|
2018-11-08 |
2021-08-03 |
Gammadelta Therapeutics Ltd |
métodos para isolamento e expansão de células
|
|
WO2020101361A1
(ko)
|
2018-11-14 |
2020-05-22 |
주식회사 녹십자랩셀 |
형질전환된 t세포를 이용한 제대혈 유래 자연살해세포의 배양방법
|
|
CN111205361B
(zh)
|
2018-11-22 |
2022-05-06 |
海珂分子（北京）科技有限责任公司 |
白介素21蛋白(il21)突变体及其应用
|
|
EP3656851A1
(en)
|
2018-11-23 |
2020-05-27 |
Technische Universität Dresden |
Artificial hla-positive feeder cell lines for nk cells and uses thereof
|
|
EP3886877A4
(en)
|
2018-11-26 |
2022-08-24 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
WO2020112493A1
(en)
|
2018-11-29 |
2020-06-04 |
Board Of Regents, The University Of Texas System |
Methods for ex vivo expansion of natural killer cells and use thereof
|
|
CA3125529A1
(en)
|
2019-01-07 |
2020-07-16 |
Inhibrx, Inc. |
Polypeptides comprising modified il-2 polypeptides and uses thereof
|
|
WO2020172328A1
(en)
|
2019-02-20 |
2020-08-27 |
Rutgers, The State University Of New Jersey |
Expansion of natural killer and chimeric antigen receptor-modified cells
|
|
CU24712B1
(es)
|
2019-03-15 |
2024-07-10 |
Centre Hospitalier Univ Vaudois |
Método para la expansión y diferenciación de linfocitos t y células nk en terapias de transferencia adoptiva
|
|
KR20220004992A
(ko)
|
2019-03-29 |
2022-01-12 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
Car-nk 세포의 생산 방법 및 이의 용도
|
|
CN114173794A
(zh)
|
2019-06-25 |
2022-03-11 |
希望之城 |
Pdl1阳性nk细胞癌症治疗
|
|
EP4048296A4
(en)
|
2019-11-29 |
2024-01-24 |
Nkmax Co., Ltd. |
METHOD FOR PRODUCING NATURAL KILLER CELLS AND COMPOSITIONS THEREOF
|
|
US20250195574A1
(en)
|
2022-06-02 |
2025-06-19 |
Nkmax Co., Ltd. |
Method for reduction of immune checkpoint therapy related adverse events
|
|
US20250255903A1
(en)
|
2022-07-12 |
2025-08-14 |
Nkmax Co., Ltd. |
Method of treating parkinson's disease with expanded natural killer cells
|
|
WO2024036005A1
(en)
|
2022-08-10 |
2024-02-15 |
Nkmax Co., Ltd. |
Method of treating alzheimer's disease with expanded natural killer cells
|
|
WO2024036226A1
(en)
|
2022-08-10 |
2024-02-15 |
Nkmax Co., Ltd. |
Method of treating autism with expanded natural killer cells
|